RNA-targeted Drug Discovery: RNA-Small Molecule Binding Prediction

发布时间：2025-06-10 作者：浏览次数：

Speaker:	吴敏	DateTime:	2025年6月16日（周一）上午10:00
Brief Introduction to Speaker: Dr. Min Wu is currently a Principal Scientist at Institute for Infocomm Research (I2R), Agency for Science, Technology and Research (A*STAR), Singapore. He received his Ph.D. degree in Computer Science from Nanyang Technological University (NTU), Singapore, in 2011 and B.E. degree in Computer Science from University of Science and Technology of China (USTC) in 2006. He received the best paper awards in EMBS Society 2023, IEEE ICIEA 2022, IEEE SmartCity 2022, InCoB 2016 and DASFAA 2015. He also won the CVPR UG2+ challenge in 2021 and the IJCAI competition on repeated buyers prediction in 2015. He has been serving as an Associate Editor for journals like Neurocomputing, Neural Networks and IEEE Transactions on Cognitive and Developmental Systems, as well as conference area chairs of leading AI and machine learning conferences, such as ICLR, NeurIPS, KDD, etc. His current research interests focus on AI and machine learning for time series data, graph data, and biological and healthcare data.		Place:	国交2号楼201会议室
Abstract:The drug discovery pipeline is a complex, multi-stage process encompassing target identification, hit discovery, lead optimization, and clinical development. While traditional drugs mainly target proteins, RNA-targeted drug discovery focuses on developing therapeutics that directly interact with RNA molecules. In this talk, we use the hit discovery stage as an example and introduce deep learning techniques designed for RNA–small molecule binding affinity and binding site prediction. DeepRSMA is a cross-attention-based deep learning model for predicting RNA–small molecule binding affinity. It employs nucleotide- and atomic-level feature extraction modules for RNA and small molecules, respectively, and uses a transformer-based cross-fusion module to model their interactions. The final prediction integrates features from both the extraction and fusion modules. MVRBind is a multi-view, multi-scale graph convolutional network for predicting RNA–small molecule binding sites. It capture...

上一条：这是第一条
下一条：基于正则化重心映射的scATAC-seq数据整合方法